award Archives

BNMC & Partners Awarded up to $8.2 Million to Improve Transportation Access.

February 18, 2021 by Maria Morrealein Collaboration, Commuting, Innovation, News

The United States Department of Transportation (USDOT) has selected the Buffalo Niagara Medical Campus (BMNC) as one of five U.S. locations to pilot the Complete Trip – ITS4US Deployment Program. The Complete Trip – ITS4US Deployment Program challenges communities to identify ways to provide more efficient, affordable, and accessible transportation options for underserved populations that often face greater challenges in accessing essential services.

Continue reading “BNMC & Partners Awarded up to $8.2 Million to Improve Transportation Access.”

UB, Kaleida Win Green Construction Award

June 20, 2013 by BNMCin Construction, Homepage, Member Institution(s), News, Sustainability

UB Reporter Story: Published June 20, 2013

The new medical building in downtown Buffalo shared by UB and Kaleida Health received two honors at a local construction awards ceremony.

The 11th annual “Brick by Brick” awards, presented by Buffalo Business First, recognized Kaleida’s Gates Vascular Institute and UB’s Clinical and Translational Research Center, which occupy the same footprint at the burgeoning Buffalo Niagara Medical Campus.

The $291-million building, a significant step in UB’s effort to relocate its medical school downtown, won the Golden Brick award, which is essentially the ceremony’s building of the year award.

Kaleida occupies the building’s lower floors, which are dedicated to the surgical and interventional management of cardiac, vascular and neurological conditions, as well as a 16-bed highly specialized intensive care unit and a 62-bed short-stay unit.

UB is using its portion of the building to expand its focus on translating basic medical research into new medical breakthroughs, innovative treatments and new economic opportunities.

The building also took the “Best Green Project” award.

The UB portion was designed to be certified gold under the U.S. Green Building Council’s Leadership in Energy and Environmental Design (LEED) program. It has an array of sustainability features that minimize how much energy the building consumes and make use of natural light.

Additionally, the building is located near mass transit systems and is composed of materials from local sources.

UB last year received two “Brick by Brick” awards: one for Barbara and Jack Davis Hall, the new School of Engineering and Applied Sciences building, and the other for the William R. Greiner Residence Hall, a sophomore dormitory.

UB RIA Awarded Grant to Develop Telephone-based Clinical Skill Assessment Tool

March 22, 2013 by BNMCin Homepage, Member Institution(s), News2 Comments

Can alcohol and drug abuse clinician skills be assessed over the phone?

There is a growing trend to make clinical training available to alcohol and drug abuse treatment professionals via the Internet and through distance learning. It is cost effective and can deliver training in current evidence-based practices to audiences for whom access may be limited.

While ensuring that trainees can correctly wp-contently the clinical skills taught during training is crucial, evaluation of whether or not clinical skills are correctly wp-contentlied can be challenging because it is typically done through role playing. The assessment of role playing requires feedback as well as reviewing the wp-contentlication of that feedback.

When training is delivered via the Internet and/or through distance learning, clinical skills wp-contentlication assessment might require tools such as video conferencing, which are cost-prohibitive for many organizations.

The University at Buffalo Research Institute on Addictions (RIA) has been awarded a $267,469 National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant to refine a telephone-based clinical assessment tool for evaluating the training of drug and alcohol counselors – a tool that is built on existing data – and then to conduct a psychometric evaluation for its effectiveness.

“The idea for the grant came about because of a challenge we encountered on a previous study — the ‘Behavioral Interventions with Couples Project’ or BIC project,” said Christopher Barrick, PhD, RIA research scientist and the principal investigator on the new grant.

According to Barrick, the previous study involved expert clinicians in the field of substance abuse who were trained in behavioral couples therapy. The research compared the effects of being trained at an in-person workshop versus distance learning via video conference. The objective was to assess gains in knowledge and clinical skill following the workshop. Assessing knowledge was straightforward – trainees were asked to respond to a web-based questionnaire.

“Assessing clinical skill was more complicated,” said Barrick.

“How could we conduct a role play, a traditional method of clinical skill assessment, with our distance-learning trainees, many of whom were in the greater Rochester area? Sending research staff to conduct in-person role plays would have been too time-consuming and costly.

“To address this need, we developed a method that used interactive voice recording (IVR). Essentially, trainees telephoned in and the IVR system acted like a sophisticated voice mail system, capturing unrehearsed responses to clinical questions. It was a good start, but the method needs refinement. That’s the goal of this current research grant.”

Barrick says the specific goals of the project are to refine and extend the existing assessment tool developed in the BIC project, and conduct a psychometric evaluation to examine the generalizability, alternate form reliability and construct validity of the tool.

“My co-investigator at RIA, Dr. Neil McGillicuddy, also a research scientist at the UB Research Institute on Addictions, has had experience developing similar instruments before, and I’m excited to collaborate with him on this project,” said Barrick.

Barrick says this particular project focuses on developing a methodology that could be used in a variety of fields.

“It just hwp-contentens that there is a trend toward making trainings available to substance abuse treatment clinicians via the Internet and other distance learning methods, so this is a good fit with the broader needs of the field at the moment.

“There is a lot of great treatment and intervention research currently going on in the substance abuse field. Unfortunately, there has been an ongoing problem of transferring that work into community practice. This project is a part of this broad area of research that looks at better ways to make the big investment in treatment and intervention research pay off and gets those results into the hands of people who can use it,” he said.

The grant is scheduled to run from December 2012 to December 2014.

Sara R. Saldi (UB); saldi@buffalo.edu; 716.645.4593

New Vaccine Research Aims to Prevent Recurrent Ear Infections

January 7, 2013 by BNMCin Homepage, Life Sciences Companies, Member Institution(s), News3 Comments

Lab in UB’s Clinical and Translational Research Center is one of few in the world studying an increasingly prevalent bacterium, once considered harmless
Children’s ear infections cause more than pain and sleepless nights; they temporarily disrupt hearing when children are at a critical age for speech and language development. They also have major social and economic costs.

But while infants and children receive immunizations against infections caused by Haemophilus influenzae and pneumococcus, there is no vaccine against Moraxella catarrhalis, an increasingly prevalent bacterium that causes at least ten percent of otitis media cases.

Now, University at Buffalo scientists, among just a handful of researchers in the world studying this organism, have received a $1.5 million National Institutes of Health (NIH) grant to develop a vaccine against it. The researchers are among the first tenants in UB’s Clinical and Translational Research Center, which opened in September on the Buffalo Niagara Medical Campus.

The goal of the current research, funded by the NIH’s National Institute on Deafness and Other Communication Disorders, is to identify new virulence mechanisms for this understudied pathogen, identify the structure of a candidate antigen for a new vaccine and develop a new vaccine.

According to Timothy F. Murphy, MD, SUNY Distinguished Professor of Medicine and Microbiology in the UB School of Medicine and Biomedical Sciences and principal investigator on the NIH grant, research on M. catarrhalis has lagged because it was originally believed to be a “commensal” or harmless bacterium. While it does cause milder cases of middle ear infections (otitis media) than other bacteria, Murphy said it is becoming more prevalent. Preliminary evidence also shows that existing ear infection vaccines are changing colonization patterns among otitis media pathogens, possibly increasing the prevalence of M. catarrhalis infections.

“Of the 15 to 20 million cases of otitis media each year in the U.S., about ten percent are recurring, causing incredible disruption for the child and the family,” explains Murphy. “When a child has the infection, the middle ear fills with fluid, a condition that can last for a month or longer. During that time, the child’s hearing is muffled, which disrupts the normal development of language and speech skills, potentially resulting in long term delays and learning problems in school.”

Recurrent ear infections also require repeated courses of antibiotics, which then contribute to the global problem of antibiotic resistance. Some children must undergo insertion of drainage tubes under general anesthesia.

“The best option would be to prevent these infections in the first place,” says Murphy.

The goal of the UB researchers is to identify M. catarrhalis antigens that are very similar among all strains so that a vaccine based on a single antigen will protect against as many strains of the bacterium as possible.

“Based on our results thus far, it looks like we will be able to identify antigens that are identical or very similar among all strains and genetic lineages,” says Murphy.

He and his colleagues are using bioinformatics to identify genes predicted to encode proteins on the surface of the organism, construct a gene chip to test which of more than 300 possible genes on the surface are identical or similar among multiple strains and then clone genes for some of the predicted proteins for testing in in vitro and mouse models.

The UB group is now testing several promising vaccine antigens that they have identified. A new vaccine could be ready for human testing in three to five years.

Murphy and his colleagues at UB are global leaders in the study of M. catarrhalis in otitis media in children and chronic obstructive pulmonary disease (COPD) exacerbations in adults. Their hope is that the same vaccine could be used to prevent both kinds of infections.

In addition to directing the M. catarrhalis research, Murphy directs UB’s Clinical and Translational Research Center and is senior associate dean for clinical and translational research in the UB medical school. For more than a decade, Murphy has studied how M. catarrhalis causes both otitis media in children and infections in chronic obstructive COPD in adults.

Ellen Goldbaum (UB); goldbaum@buffalo.edu; 716.645.4605

Roswell Park Recognizes Staff, Community Supporters at 5th Annual Eva M. Noles Progra

December 13, 2012 by BNMCin Community, Event, Member Institution(s), News5 Comments

FOR IMMEDIATE RELEASEDecember 12, 2012
Contact: Annie Deck-Miller, Senior Media Relations Manager
716-845-8593; annie.deck-miller@roswellpark.org

Roswell Park Recognizes Staff, Community Supporters at 5th Annual Eva M. Noles Program
Scholarship awarded to RPCI employee in tribute to Buffalo’s first African-American nurse

BUFFALO, NY — DeMarco Ogletree, a cashier in the Nutrition & Food Service Department at Roswell Park Cancer Institute (RPCI), earned the $2,000 Eva M. Noles Scholarship Friday, December 7 at the fifth annual Eva M. Noles Scholarship and Community Recognition Breakfast at RPCI. The annual program honors the legacy of Eva M. Noles, RN, Buffalo’s first African-American registered nurse and a longtime RPCI employee who served in many leadership roles at the Institute, including as Director of Nursing.

Ogletree joined the Roswell Park staff in the spring of 2012. He is presently pursuing degrees in both nursing and theology at Erie Community College and plans to continue his work in healthcare, helping to fight health disparities in the Buffalo area. “From his first days with us, DeMarco has committed himself wholeheartedly to the Roswell Park mission,” said David Scott, RPCI Director of Diversity and Inclusion. “He has contributed greatly as an employee, and now we have a great opportunity to reward that commitment — which embodies the work, spirit and legacy of Ms. Noles — and help him achieve his career goals by providing a scholarship toward his studies.”

Darius G. Pridgen, Pastor of True Bethel Baptist Church in Buffalo and Ellicott District Councilmember for the City of Buffalo, gave the keynote address at the program, during which several RPCI staff members and volunteers were recognized for their role in providing cancer education and preventive outreach to underserved communities throughout Western New York. Among those recognized were Georganne Alexander, a volunteer with the Buffalo/Niagara Witness Project; Ramon Luciano Jr., a volunteer with Minorities Allied for the Need to Understand Prostate Cancer (MAN UP); Carmen Sepulvedad, a volunteer with the Esperanza y Vida Project; and Gloria Quarles, a volunteer who serves on Roswell Park’s Community Advisory Steering Committee.

Staff and volunteers were also recognized for their contributions to Cruisin’ for a Cure, a prostate cancer education and screening event held at RPCI in September, and to the African American Roswell Employee Network, whose activities include year-round community outreach on behalf of RPCI.

The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email askrpci@roswellpark.org.

GO Bike Buffalo Receives National $50,000 Grant from Play Streets®

November 15, 2012 by BNMCin Community, Environment, Healthy Communities, Homepage, News, Wellness5 Comments

GO Bike Buffalo has announced that they have received a $50,000 grant from Play Streets®, an initiative created to help prevent and combat childhood obesity by the Partnership for a Healthier America and the Blue Cross and Blue Shield Association.
As 1 out of 10 cities chosen to receive the award, Buffalo will continue on its journey to create a city where alternative modes of transportation, healthy communities, and the education of the future generations are a top priority.

In addition to GO Bike Buffalo, collaborators include BlueCross BlueShield of Western New York, the City of Buffalo and the Common Council. The award will help to make the City of Buffalo a place where children can play in the streets safely as they are provided with more options the stay active and healthy.

The President and CEO of BlueCross BlueShield of Western New York, Alphonso O’Neil-White, stated that “BlueCross BlueShield sees Play Streets® as a transformative program that will improve the health of our region and inspire people to make healthy choices.”

For one year, Buffalo, including the other 9-city award recipients (Minneapolis, MN, Savannah, GA, Durham, NC, New Orleans, LA, Omaha, NE, York, PA, San Francisco, CA, Chicago, IL, and Caguas, PR) will host Play Streets® events that will result in closing designated streets to traffic making the play-friendly road open to the community. In addition to the funds, each awardee will receive technical assistance, and communications and marketing support from the Partnership for a Healthier America, Blue Cross and Blue Shield Association, and local Blue Cross and Blue Shield companies to help promote the events that will take place in each community.

GO Bike Buffalo’s efforts to create healthy, environmentally sustainable, community-friendly transportation options in the City of Buffalo have not gone unnoticed. The non-profit organization’s dedication to local initiatives like the Complete Streets, GO Buffalo, Buffalo Green Code, Healthy Kids, Healthy Communities, and more has made a substantial impact in the community.

Justin Booth, Executive Director of GO Bike Buffalo stated that “GO Bike Buffalo is proud to introduce Play Streets® to the City of Buffalo in partnership with the Health Kids, Healthy Communities initiative to create safe, accessible and healthier communities by opening our streets so individuals and families can come together to participate in fun, healthy activities.”

A major contributor of childhood obesity is inactivity. It is recommended that children take part in physical activities for at least 1 hour per day. According to the Project HOPE. Child Obesity Policy Brief: The Pervasive Effects Of Environments On Childhood Obesity, 1 out of every 5 children (15 million) in America do not have access to a playground. In that same policy brief, more than a third of the children in this country are said to have no access to recreation centers in their immediate communities. Play Streets® is an effective solution that offers a high-impact way to encourage more physical activity in neighborhoods that often lack open space.

The grant will help to promote walking and cycling this summer and will hopefully pave the way for continued and more frequent Play Streets® support in the future.

Visit gobikebuffa.org to stay up-to-date on the progress and events that emerge from the award.

Glick Receives National Editorial Award for Third Consecutive Year

November 5, 2012 by BNMCin Member Institution(s), News2 Comments

For release: November 5, 2012Sara R. Saldi; saldi@buffalo.edu
University at Buffalo
716-645-4593

Glick Receives National Editorial Award for Third Consecutive Year

BUFFALO, N.Y. — Michael Glick, DMD, professor and dean of the University at Buffalo School of Dental Medicine, has been awarded the American Dental Education Association’s (AADE) William J. Gies Foundation First Place Editorial award for the third year in a row. The presentation of the award was made during the annual meeting of the American Association of Dental Editors (AADE) Oct. 17 in San Francisco.

A photo of Glick is available at: http://www.buffalo.edu/news/13782.

Since 1958 the William J. Gies Editorial Award has been presented yearly to the author of the most valuable editorial published in a dental journal or periodical. The AADE and the William J. Gies Foundation for the Advancement of Dentistry of the American Dental Education Association (ADEA Gies Foundation) collaborate each year to identify and recognize award recipients.

Glick received the 2012 award for his editorial in the Journal of the American Dental Association (JADA): “Clinical Judgment: A Requirement for Professional Identity.” He won the same award in 2011 for his JADA editorial, “Education and Training: Two Different Proficiencies Necessary to Provide Oral Health Care” and in 2010 for a JADA editorial, “Expanding the Dentist’s Role in Health Care Delivery: Is it time to discard the Procrustean bed?”

The award is named for William J. Gies, a biochemistry professor from Columbia University who, in 1926, published a landmark report on dental education in the U.S. and Canada. Each year, dental editors from across the country submit their best editorials to be considered for the award. The editorials are reviewed by the William J. Gies Foundation Editorial Award Judging Committee, which makes the selection.

Glick, who became UB dean in December 2009, is editor of JADA, the premier, peer-reviewed journal in dentistry. Glick is known for his innovative, medicine-oriented wp-contentroach to dental care; he is an advocate for having dental students think of themselves as health care professionals first, and dentists second.

This is the fourth year in a row that a faculty member from UB’s School of Dental Medicine has won the award. In addition to Glick’s awards in 2010 and 2011, Chester J. Gary, DDS, JD, clinical assistant professor in restorative dentistry, was the recipient in 2009.

Glick has published more than 200 articles, book chapters and monographs on topics related to oral medicine. He has also led the way in the area of clinical dental care for medically complex patients, including those with HIV. He is a proponent for dentists to become involved in the overall health and well-being of their patients, which may include chair-side screening of dental patients for cardiovascular disease and other chronic illnesses.

J. Craig Venter Receives Honorary Doctorate, Extols Virtues of the CTRC, UB's Newest Research Facility

September 24, 2012 by BNMCin Homepage, Member Institution(s), News, ResearchLeave a Comment

“I’m actually jealous,” said J. Craig Venter, speaking of UB’s Clinical and Translational Research Center, after receiving the SUNY Honorary Doctorate in Science.

World-renowned genomic researcher calls UB facility “some of the most beautiful lab space I’ve seen.”

J. Craig Venter, PhD, the pioneering biologist who led the first team to sequence the human genome, received a State University of New York Honorary Doctorate in Science at the University at Buffalo on Sept. 20. The honorary degree was conferred on him at a ceremony that followed the grand opening of UB’s Clinical and Translational Research Center in the joint UB-Kaleida Health building in downtown Buffalo.

UB President Satish K. Triapthi called Venter “one of the 21st century’s most influential scientists and widely regarded as the world’s foremost leader in the field of genetic research.” He said he couldn’t think of a more fitting individual to honor on the occasion of the CTRC opening.

The degree was conferred on Venter by Angelo Fatta, UB Foundation board of directors chair, and SUNY Trustee Eunice Lewin.

Venter, a former UB and Roswell Park Cancer Institute scientist, developed a revolutionary strategy for rapid gene discovery while working at the National Institutes of Health. He later founded The Institute for Genomic Research and, in 1995, he and his team decoded the genome of the first free-living organism. At Celera Genomics, which he founded in 1998, Venter sequenced the human genome using new tools and techniques he and his team developed. The successful completion of this research culminated with the February 2001 publication of the human genome in the journal Science.

Speaking before the audience that gathered in the fifth floor atrium of the CTRC, Venter expressed his honest admiration for UB’s newest research facility.

“I’m actually jealous,” he said, after accepting the SUNY honorary degree. “This is some of the most beautiful lab space I’ve seen and the views are always improving.” Venter then described his newest building, now under construction on the University of California San Diego campus, which, he conceded, will have even better views because it is located right next to the Pacific Ocean.

In addition to the CTRC’s physical assets, Venter praised UB and Buffalo for committing to the creation of a life sciences economy. “I’m a strong believer that the future does rest in a bioeconomy,” he said.

Venter also gave an update on genomics, describing the massive amounts of digital information that the research has produced and the challenge caused by this “digitizing of biology.” While the mammalian genome has largely been completed, he said, there is plenty of genetic diversity on the planet that has yet to be discovered.

“By sequencing the microbiome, we find we are not alone,” he said. “In addition to the 2 million human genes we have, each of us also contains about 10 million additional microbe genes. We live in a microbial world; we are visitors here.”

He and his colleagues are also looking at the vast genetic diversity in the ocean. “Every time we take a sample of seawater, we see between 1 and 3 million genes that haven’t been seen before,” he said.

While noting that the idea that it’s possible to sequence your own genome for about $1,000 may be an overstatement, he said that personalized medicine based on a patient’s genetic information “will be a standard part of medicine within a few years.”

Venter is founder and president of the J. Craig Venter Institute, a not-for-profit, research and support organization dedicated to human, microbial, plant and environmental genomic research, the exploration of social and ethical issues in genomics, and alternative energy solutions through genomics. He and his team continue to blaze new trails in genomics research and have published numerous important papers covering such areas as the first complete diploid human genome, environmental genomics and synthetic genomics.

Venter also is founder and chief executive officer of the company Synthetic Genomics Inc., a privately held company commercializing genomic advances.

Ellen Goldbaum; goldbaum@buffalo.edu; 716-645-4605; @egoldbaum

All in One Day: Three Awards for the Buffalo Niagara Medical Campus

September 20, 2012 by BNMCin Campus-wide, Innovation Center, Member Institution(s), NewsLeave a Comment

The Buffalo Niagara Medical Campus (BNMC) received three honors on the same day this week: the BNMC was named 2012 Outstanding Research/Science Park by the Association of University Research Parks (AURP); its Four Neighborhoods, One Community: Buffalo Niagara Medical Campus Master Plan Update has been awarded the 2012 Planning Excellence Award for Comprehensive Planning by the New York Upstate Chapter of the American Planning Association (NYUAPA); and the Thomas R. Beecher Innovation Center, owned and operated by the BNMC, Inc., received the Innovative Design Award by international trade organization Global Workspace Association.

2012 Outstanding Research/Science Park Award by Association of University Research Parks (AURP)

Patrick J. Whalen, Chief Operating Officer of the Buffalo Niagara Medical Campus, Inc., was on hand to accept the award at AURP’s annual conference in Madison, WI.

“The Association of University Research Parks is pleased to announce the 2012 Awards of Excellence recipients and has named the Buffalo Niagara Medical Campus the 2012 Outstanding Research Park,” said AURP President Kevin Byrne. “BNMC is a world-class medical campus that has created a strong community of innovation in Buffalo and throughout the region. We congratulate them for their outstanding achievements.”

AURP is a professional association of university related research and science parks. The association’s mission is to foster innovation, commercialization and economic growth through university, industry and government partnerships. More online at www.aurp.net.

Previous parks honored as Outstanding Research/Science Park of the Year include the Research Park at the University of Illinois at Urbana-Champaign; Virginia Tech Corporate Research Center; Innovation Place (Saskatoon, Saskatchewan, Canada); Sandia Science & Technology Park (Albuquerque, NM); and Centennial Campus at North Carolina State University.

Buffalo Niagara Medical Campus Receives Three Honors in One Day by Different International & State-Wide Organizations

September 20, 2012 by BNMCin Campus-wide, NewsLeave a Comment

For Immediate Release
Thursday, September 20, 2012

For more information:
Contact Kari Bonaro
kbonaro@bnmc-old.local, 716-218-7157

Buffalo Niagara Medical Campus Receives Three Honors in One Day by Different International & State-Wide Organizations

Received Outstanding Research/Science Park, Planning Excellence, and Innovative Workspace Awards

(BUFFALO, NY) – The Buffalo Niagara Medical Campus received three honors on the same day this week: the BNMC was named 2012 Outstanding Research/Science Park by the Association of University Research Parks; its Four Neighborhoods, One Community: Buffalo Niagara Medical Campus Master Plan Update has been awarded the 2012 Planning Excellence Award for Comprehensive Planning by the New York Upstate Chapter of the American Planning Association (NYUAPA); and the Thomas R. Beecher Innovation Center, owned & operated by the BNMC, Inc., received the Innovative Design Award by international trade organization Global Workspace Association.

2012 Outstanding Research/ Science Park Award by Association of University Research Parks (AURP)

Patrick J. Whalen, Chief Operating Officer of the Buffalo Niagara Medical Campus, Inc., was on hand to accept the award at AURP’s annual conference in Madison, WI. The BNMC has submitted a proposal to host the group’s 2014 meeting here in Buffalo.

The Association of University Research Parks is a professional association of university related research and science parks. AURP’s mission is to foster innovation, commercialization and economic growth through university, industry and government partnerships. More online at www.aurp.net.

2012 Planning Excellence Award for Comprehensive Planning from the New York Upstate Chapter of the American Planning Association

In addition, the New York Upstate Chapter of the American Planning Association (NYUAPA) announced that the Four Neighborhoods, One Community: Buffalo Niagara Medical Campus Master Plan Update has been awarded the 2012 Planning Excellence Award for Comprehensive Planning. The 2012 NYUAPA Awards recognize outstanding work that is being done by planners and planning firms in Upstate New York. Planning Excellence Award for Comprehensive Planning recognizes plans that advance the science and art of planning.

2012 Innovative Design Award by the Global Workspace Association

About the BNMC

The Buffalo Niagara Medical Campus (BNMC) is dedicated to the cultivation of a world-class medical campus for clinical care, research, education, and entrepreneurship on 120 acres in downtown Buffalo. It is home to the region’s top clinical, research, and medical education institutions, including: the University at Buffalo, Roswell Park Cancer Institute, Olmsted Center for Sight, Kaleida Health, Hauptman-Woodward Medical Research Institute, Buffalo Medical Group, Buffalo Hearing & Speech Center, Unyts, and the Center for Hospice and Palliative Care. There are over 40 public and private companies on the BNMC. More than 12,000 people come to work at the Medical Campus every day, and BNMC institutions see over one million patients and visitors annually. The Campus has an annual economic impact of $1.5 billion on the region. The Medical Campus consists of more than 6 million square feet of research, clinical, and support space. bnmc-old.local

About the BNMC, Inc.

###

UB Awarded $1.6M Grant for Students to Study Cybersecurity

September 18, 2012 by BNMCin Member Institution(s), ResearchLeave a Comment

News Release

Cory Nealon

cmnealon@buffalo.edu

716-645-4614

Release Date: September 18, 2012

BUFFALO, N.Y. — The University at Buffalo has received a $1.6 million federal grant to teach students how to protect the United States from cyberattacks.

UB will use the grant, awarded by the National Science Foundation, to bring up to 16 students into its Center of Excellence in Information Systems, Assurance, Research and Education (CEISARE). It is one of wp-contentroximately 50 federally designated centers that supply the United States with graduates trained to protect the nation from computer-based attacks. For more information, visit: http://www.cse.buffalo.edu/caeiae.

The grant will cover the cost of student stipends ($25,000), in-state graduate tuition and fees ($12,000) and books, travel expenses and health insurance ($3,000) for two years. At roughly $80,000 per student, this equals $1.3 million. The remainder of the grant, roughly $345,000, will cover the cost of running the center for five years.

In exchange for the financial support, students must agree to work for the federal government for two years upon graduation. CEISARE Director Shambhu Upadhyaya said students can choose from numerous agencies including the National Security Agency, the Department of Homeland Security, the Department of Defense and the FBI.

“When students graduate with a specialty in cybersecurity, they can basically go wherever they want,” said Upadhyaya, professor of computer science and engineering.

For a picture of Upadhyaya, visit: http://ubphoto.smugmug.com.

An interdisciplinary program, CEISARE includes a varied group of UB faculty. For example, the grant’s co-investigators are: Thomas Cusick, professor of mathematics; H. Raghav Rao, SUNY Distinguished Service Professor in management science and systems department; and Mark Bartholomew, associate professor of law.

The diversity reflects the nuances of computer warfare, which Homeland Security Secretary Janet Napolitano has said is the most serious economic and national security threat that the United States faces. She and other national security officials have warned that electric grids, transportation systems, banks and other industries reliant on computer systems are susceptible to cyberattacks.

Upadhyaya pointed to the 2009 hacking of sensitive information from the Pentagon’s $300 billion, F-35 Joint Strike Fighter project as an example.

The $1.6 million grant is the second multi-year award received by CEISARE. In 2008, it received $860,000 to educate 11 students, some of whom went on to work for the National Security Agency, the Federal Trade Commission and the Office of Inspector General.

Division within WCHOB Department of Pediatrics Receives $1.1 M Grant

September 17, 2012 by BNMCin Health care, Homepage, Member Institution(s), News, WellnessLeave a Comment

The Women & Children’s Hospital of Buffalo’s (WCHOB) Division of Neonatology received a grant for $1.1 M from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. A published SUPPORT report trial revealed that there is a lack of knowledge regarding oxygen supplementation, delivery and toxicity in newborn infants. The Optimal Oxygenation in Neonatal Lung Injury grant will be used to propel the research focusing on infant oxygen supplementation.
Neonatal resuscitation is necessary when an infant is asphyxiated. When an infant is born, its pulmonary circulation shifts in order to adjust to the environment outside of the womb. When that adjustment is not flawless and is met with immediate complications, the result can be a condition called Persistent Pulmonary Hypertension of the Newborn (PPHN) which can be fatal.

Dr. Satyan Lakshminrusimha, the Chief of the Division of Neonatology and Associate Professor of Pediatrics at the University at Buffalo, is the grant’s principal investigator. His research focuses on the pathophysiology of the cardio-pulmonary transition – how fetal lungs change at birth in order to breathe air – and disorders of this transition such as birth asphyxia, PPHN, retained lung liquid and respiratory distress syndrome.

The Division’s research goals are to deliver the best critical care to infants with respiratory depression at birth and reduce oxygen toxicity; to discover the optimum management of newborns with PPHN; and to further the treatment of necrotizing enterocolitis (NEC), a gastrointestinal disease that disproportionately affects pre-term infants.

The grant’s disbursement over a 5-year period, with $235, 523 given to the Division each year will go towards the collection of physiological data that will help to establish guidelines for optimal oxygen delivery to premature infants.

The WCHOB has the region’s only level 4 unit in its Neonatal Intensive Care Unit, meaning it can provide immediate trauma care that can evaluate, diagnose, and stabilize patients, also offering a degree of surgery and critical care services. The hospital is Western New York’s center for state-of-the-art pediatric, neonatal, perinatal and obstetrical care.

WTCBN Receives Funds to Help Increase Medical Device Trade Between WNY Manufacturers and China

September 6, 2012 by BNMCin Entrepreneurs, Investment Opportunities, NewsLeave a Comment

The World Trade Center of Buffalo Niagara (WTCBN), a local not-for-profit international business development organization helping to facilitate regional growth through global trade, has received nearly $682,000 to help increase medical device trade between Western New York (WNY) manufacturers and China. In that pot of money is $218,000 from the U.S. Department of Commerce.
Through a program that will be administered over a three-year time period, WTCBN and partners that work with medical device companies will enhance trade relations knowledge to place devices in one of the largest populace nations in the world. Partners include the University at Buffalo’s New York State Center of Excellence in Bioinformatics and Life Sciences, the Buffalo Niagara Medical Campus, The Buffalo Niagara Partnership, MedTech, the Jacobs Institute and the Department of Commerce, in addition to others who assist and house medical device companies.

“This three-year project will serve as a template for a greater regional export strategy,” said Chris Johnston, president of WTCBN. Johnston also stated that it will be “a great opportunity for collaboration among various groups, including the federal, state and regional government, with local organizations such as the Buffalo Niagara Medical Campus, UB and World Trade Center Buffalo Niagara, which will maximize the benefits for Western New York companies.”

The Accelerating Upstate New York’s Competitiveness and Exports in the Global Economy program will offer training and expertise to least 40 local manufacturers, teaching them how to navigate Chinese import laws, how to effectively market their products in China and the logistics of shipping goods there. They will also provide access to export loans and credit insurance. An estimated $25 million could come from Chinese contracts over a four-year period, leading to the creation of hundreds of jobs in this area.

At a roundtable discussion moderated by Congresswoman Kathy Hochul, New York’s 26th Congressional District Representative, companies had the opportunity to ask questions and receive feedback on how to identify and capitalize on new medical device markets, and to learn more about the program. Congresswoman Hochul said the program is “a critical step toward opening new markets, fostering innovation, and expanding manufacturing right here at home. Meaningful investment in Western New York’s medical device industry and work force will help add good-paying, sustainable jobs to our local economy.” The discussion served as an indicator of the collaboration and knowledge-sharing between experts and companies that is soon to come.

Congresswoman Hochul also said “It is vital that we continue to work to ensure our local businesses have the resources necessary to expand and reach new global markets.” With over $1.9 trillion in exportation of goods and services in 2011, China is currently the largest exporting country in the world. Efforts to increase the importation of medical devices made from the U.S., more so in the WNY region to China, will undeniably generate revenue increases for many local companies.

The U.S. Commerce Secretary, Rebecca Blank, stated that “The awards given by the Commerce Department’s Market Development Cooperator Program will help us continue to make progress toward achieving the President Obama’s goal of doubling exports by the end of 2014. Higher exports lead to more jobs: in 2011, jobs supported by exports increased by 1.2 million over 2009.”

The Buffalo Niagara Medical Campus, Inc.’s COO, Patrick J. Whalen stated that “the Department of Commerce grant will showcase the assets in Western New York to medical device companies around the world, and we look forward to working together to help existing companies succeed and grow.”

While WNY is home to nearly 250 medical equipment manufacturers and medical research centers, WTCBN reports that an overwhelming majority of the companies export their goods to the one country it is closest to which is Canada. Past innovations from the region include the implantable pacemaker, the Prostate-Specific Antigen (PSA) test, photodynamic therapy (used to treat malignant cancers), and multiple sclerosis therapy.

The inaugural session of the 2012-13 Life Sciences Commercialization Lecture Series will present an opportunity for local companies to learn more about the program. The session will take place on Thursday, September 27 from 4-5 p.m. at the New York State Center of Excellence in Bioinformatics and Life Sciences located at 701 Ellicott Street. For more information and to register for the event, click here.

At International Cardiology Meeting, UB Chair of Medicine is Honored for Her Distinguished Clinical Research

August 22, 2012 by BNMCin Member Institution(s), News, ResearchLeave a Comment

News Release

At International Cardiology Meeting, UB Chair of Medicine is Honored for Her Distinguished Clinical Research

UB’s Curtis is one of the world’s leading clinical cardiac electrophysiologists and an expert in cardiac arrhythmias.

Contact

Ellen Goldbaum

goldbaum@buffalo.edu

716-645-4605
twitter @egoldbaum

Release Date: August 22, 2012

BUFFALO, N.Y. — Anne B. Curtis, MD, Charles and Mary Bauer Professor and Chair of the Department of Medicine in the University at Buffalo School of Medicine and Biomedical Sciences, has been awarded the Walter Bleifeld Memorial Award for Distinguished Work in Clinical Research. Bleifeld, considered one of the pioneers of modern cardiology, was a professor of medicine and cardiology at the University of Hamburg.

Curtis was presented with the award in July at the 17th World Congress on Heart Disease of the International Academy of Cardiology in Toronto.

The award recognizes Curtis’s outstanding contributions to clinical research. She is one of the world’s leading clinical cardiac electrophysiologists and an expert in cardiac arrhythmias. Her clinical research has significantly advanced knowledge of human cardiac electrophysiology and heart-rhythm abnormalities.

Curtis’s research interests include clinical trials in implantable device therapy for prevention of sudden cardiac death and management of heart failure, as well as clinical trials in atrial fibrillation. She has been principal investigator, co-investigator, sponsor or steering committee member on 85 research studies and clinical trials and has written more than 250 peer-reviewed manuscripts, book chapters, reviews and editorials. She also is author of a book on cardiac pacing.

Curtis received a 2010 Distinguished Fellowship Award from the International Academy of Cardiology.

In 2011, she was a key contributor to guidelines on atrial fibrillation that are issued periodically by the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Earlier this year, she received the 2012 Distinguished Service Award from the Heart Rhythm Society.

She lives in Buffalo.

UB CAT Awards More Than $415,000 to 16 WNY Companies Developing Life Sciences Technologies

July 18, 2012 by BNMCin Life Sciences Companies, Member Institution(s), NewsLeave a Comment

News Release

UB CAT Awards More Than $415,000 to 16 WNY Companies Developing Life Sciences Technologies

Contact

Marcene Robinson

marcener@buffalo.edu

716-645-4650

Release Date: July 18, 2012

BUFFALO, N.Y. — The University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) has awarded more than $415,000 to companies in Western New York to aid them in the development of new life sciences technologies.

The funding will support a range of projects in the 2012-13 fiscal year, from development of eye-controlled keyboards to development of a new cancer immunotherapy. Companies must work with a UB professor as principal investigator, and also get access to UB facilities and equipment.

Firms receiving an award, which typically ranges between $10,000 and $50,000, must match the funding with their own money.

The UB CAT is one of 15 centers across New York State that Empire State Development’s Division of Science, Technology and Innovation (NYSTAR) funds to support university-industry collaboration in research, education and technology transfer. The focus is on linking academic research with commercial interests to help New York State-based businesses gain a technological edge on their competition.

UB received its most recent re-designation by NYSTAR as a Center for Advanced Technology in 2007. The designation lasts 10 years, during which the UB CAT receives nearly $1 million annually from NYSTAR.

Since 2005, the UB CAT has supported over 75 projects leading to more than $140 million in non-job economic impact. The center has also helped Western New York’s life sciences sector create over 280 new jobs.

“The UB CAT provides companies with funding and resources during a critical stage in the development of new technologies,” said Marnie LaVigne, UB associate vice president for economic development. “The projects we have supported over the years have helped create jobs in New York State, facilitated long-term partnerships between UB and industry, and led to the commercialization of new and improved life sciences products and services.”

This year, 16 businesses were chosen from a group of 22 wp-contentlicants, all vying for aid in creating new technologies that benefit the fields of health and medicine.

One such company, IMMCO Diagnostics Inc., will use its $40,000 award to develop a more sensitive and specific test for Sjogren’s syndrome, an autoimmune disease in which white blood cells attack the glands that produce tears and saliva.

The syndrome is the second most common autoimmune disease, affecting some 4 million Americans. Nine out of 10 patients are women, including tennis champion Venus Williams.

Williams was first diagnosed with this disease in 2011, but suffered with Sjogren’s for a while before doctors could determine the cause.

Current tests for Sjogren’s syndrome are not sensitive enough, missing almost two-thirds of cases. However, research by Julian Ambrus Jr., MD, rheumatologist, immunologist and an associate professor in UB’s Department of Medicine, led to the discovery of a diminished protein in those with the syndrome.

IMMCO, founded in Buffalo in 1971 by several UB professors, is one of the world’s first autoimmune disease diagnostic companies. Their lab will manufacture the new testing kits, which will detect the disease in 70 to 80 percent of patients.

“Most autoimmune diseases are difficult to diagnose, simply because we really do not know the exact causes for most of them,” said Lakshmanan Suresh, assistant vice president of lab services at IMMCO. “This collaboration between IMMCO and UB will help diagnose the disease earlier so treatment can be delivered sooner.”

He adds, “The grant also helps us get this test from the bench stage to the market quicker.”

Information regarding the UB CAT and the center’s award wp-contentlication process is available online at http://www.bioinformatics.buffalo.edu/cat.php.

Memorial Sculpture to Honor John E. Friedlander

July 17, 2012 by BNMCin Campus-wide, Community, Health care, Homepage, Member Institution(s), VolunteersLeave a Comment

As one of the community leaders and visionaries who helped to lay the foundation for the Buffalo Niagara Medical Campus (BNMC) in 2001, the late John E. Friedlander will be honored with an art sculpture to memorialize his leadership. The BNMC came to be after visionaries in the health care industry came together to help promote wellness and economic development in the Buffalo-Niagara region. It is now a leading biomedical, research, education, business, and clinical consortium helping to fuel economic growth in the area.
He was the first President and CEO of Kaleida Health, serving from October 1996 until June 2005. Friedlander is also the former Buffalo General Medical Center President and CEO. For more than 20 years, Friedlander contributed his skills and experience to build a strong health care delivery system in Western New York and now his former colleagues, friends and family are partnering with the BNMC to honor him.

He was a dynamic visionary and respected health care leader who was loved by the community, striving to make a difference. For members of the community who would like to support the campaign efforts to actualize the John E. Friedlander Memorial Art Sculpture and recognize his deep commitment to the health of Western New York residents, click here.

Four Neighborhoods, One Community Receives Planning Award from American Planning Association

June 19, 2012 by BNMCin Allentown, Community, Event, Fruit Belt, Homepage, Networking, News, OutreachLeave a Comment

Four Neighborhoods, One Community was selected to receive the Outstanding Planning Award for Comprehensive Planning from the Western New York Section of the American Planning Association. Recognizing the planning efforts designed to create a collaborative partnership between City of Buffalo and the Fruit Belt, Downtown, and Allentown neighborhoods, the initiative integrates the shared vision of community leaders, residents, and business owners within the surrounding neighborhoods with the planning that takes place throughout the campus. These collaborative efforts are paving the way for the use of this initiative as a best-practice model as it continues to gain recognition.
“the Medical Campus is blessed to be surrounded by neighborhoods that are collaborative and active in shaping their future,” said Michael Ball, the Director of Planning and Implementation for the Buffalo Niagara Medical Campus, Inc. “Four Neighborhoods, One Community will position Buffalo as a national model for how the Medical Campus as an urban campus and economic development engine can effectively develop and grow in conjunction with surrounding neighborhoods for the benefit of the greater community.”

Over 100 residents, business owners, employees, and community members gathered to discuss the changes they would like to see in their neighborhoods. As a strategic plan, Four Neighborhoods, One Community focuses on engagement that is designed to further integrate Medical Campus-wide planning efforts as well as those of the individual BNMC institutions with those occurring in the surrounding community.

It is the desire of all stakeholders involved that this initiative continues to produce tangible results as the dialogue moves forward identifying, addressing, resolving the issues that stifle economic development, neighborhood sustainability, and the improved health for all individuals that have connection to the Buffalo Niagara Medical Campus and are in one of the near-by neighborhoods.

The outcome-goals manifesting from the planning include workforce development, streetscape improvements, increased transportation options, environmental sustainability changes, and policy improvements to help create healthy communities. The purpose of this initiative is not to keep growth within the Medical Campus, but to combine and improve resources in order that community goals might align with institutional goals to enhance the overall attractiveness of the City of Buffalo.

Roswell Park Graduate Student Earns Research Scholar Award from Nicolay Foundation

May 7, 2012 by BNMCin Member Institution(s)Leave a Comment

FOR IMMEDIATE RELEASEMay 7, 2012
Contact: Annie Deck-Miller, Senior Media Relations Manager
716-845-8593; annie.deck-miller@roswellpark.org

Roswell Park Graduate Student Earns Research Scholar Award from Nicolay Foundation

BUFFALO, NY — Maryann Mikucki, a pre-doctoral trainee in the Department of Immunology at Roswell Park Cancer Institute (RPCI), has received a Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation (JMNMF). As part of the JMNMF’s ongoing support for promising graduate students at major academic cancer centers, the competitive award includes a $10,000 grant toward Mikucki’s research on melanoma, the most dangerous form of skin cancer.

Mikucki is working toward a joint MD/PhD degree from the University at Buffalo (UB) and the Roswell Park Graduate Division of UB. One of nine graduate students to receive the awards this year, she works under the direction of Sharon S. Evans, PhD, whose internationally recognized laboratory investigates checkpoints controlling mobilization of blood-borne T cells to tissues during immune responses.

“The work I’ll be performing with the Nicolay grant aims to understand the mechanism by which tumor cells interfere with delivery of toxic T cells to melanoma tumor tissues, allowing them to evade destruction,” noted Mikucki, a native of Danbury, CT, who now lives in Amherst, NY. “These proof-of-concept studies are expected to uncover a novel mechanism of melanoma resistance to T cell-based immunotherapy and also lay the foundations for translational research.”

“Our Foundation’s Research Scholar Awards are invaluable at the grassroots level, to specifically grow interest in melanoma research at qualified cancer centers across the country,” said Robert E. Nicolay, JMNMF Chairman. “If we can attract the brightest minds that are considering, or already within, the nation’s cancer research pipelines, to pursue a career in melanoma research, we’re that much closer to better understanding the disease, identifying the means for effective treatments and, most importantly, finding a cure for this deadly and very prevalent disease.”

The Joanna M. Nicolay Melanoma Foundation is a nonprofit public charity founded in January 2004 to foster melanoma education, advocacy and research. In just eight years, the Foundation has grown dramatically to become an influential voice in the melanoma community and is now established as a national, and international, “voice for melanoma prevention, detection, care and cure.”

-30-

Editor’s note: Photo caption, from left: Kelvin Lee, MD, Chair of the Department of Immunology, Sharon Evans, PhD, research mentor and Director of Graduate Studies in the Department of Immunology, Nicolay Award winner Maryann Mikucki and Richard Hershberger, PhD, MBA, Chief Academic Officer.